LabGenius
Latest round
- Series B
Last raised
- May 2024
Total raised
- $73M
Investors
- 18
About LabGenius
Established in 2012 and based in London, UK, LabGenius Limited is a biotechnology company that uses synthetic biology to develop new materials. The company uses a machine learning-driven evolution engine (EVA™) to develop protein therapeutics.
Who invested in LabGenius
18 investors across 4 rounds
See all investors in LabGenius
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about LabGenius
Who invested in LabGenius?
LabGenius has 18 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has LabGenius raised?
LabGenius has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did LabGenius last raise money?
LabGenius's most recent round on record is a Series B, in May 2024.
What does LabGenius do?
Established in 2012 and based in London, UK, LabGenius Limited is a biotechnology company that uses synthetic biology to develop new materials.
Where is LabGenius headquartered?
LabGenius is headquartered in London, UK.
Which VCs invest in companies like LabGenius?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at LabGenius's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like LabGenius? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.